Jeffrey S. Glenn, Director at Eiger BioPharmaceuticals, Inc. (EIGR), bought 10,000 shares at $11.49 ($115K) on 2020-08-11, disclosed to the SEC on 2020-08-12.
Open-market purchase of $115k EIGR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.49 | 5,000 | $57K | 50.1% |
| 2 | $11.28 | 500 | $6K | 4.9% |
| 3 | $11.44 | 4,500 | $51K | 44.9% |
| Total | $11.46 avg | 10,000 | $115K | 100% |
| Filing → |
| EIGR | BUY | 2017-09-05 | $143K | — | Filing → |
| EIGR | BUY | 2016-11-21 | $197K | — | Filing → |